Objectives: to identify primary and secondary outcome measures in randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in the first and second stages of labour, and to identify any positive health-focussed outcomes used. Design: eight relevant citation databases were searched up to January 2013 for all randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in labour. Trials of active management of labour or partogram action lines were excluded. 1918 citations were identified. Two reviewers reviewed all citations and extracted data. Twenty-six individual trials and five systematic reviews were included. Primary and secondary outcome measures were documented and analysed using frequency distributions. Findings: most frequent primary outcomes were caesarean section (n ¼15, 46%), length of labour (n ¼14, 42%), measurements of uterine activity (n ¼13, 39%) and mode of vaginal birth (n ¼9, 27%). Maternal satisfaction was identified a priori by one review and included as a secondary outcome by three papers. No further positive health-focussed outcomes were identified.
Introduction
Labour duration has shown a wide variation in different women (Albers, 1999; Vahratian et al., 2006; Neal et al., 2010) , and slow labour progress is common in nulliparous women. It is associated with childbirth complications, concerns for fetal wellbeing, and negative birth experiences (Waldenström et al., 2004) , and is one of the main indications for unplanned caesarean section in labour (Bugg et al., 2006; Florica et al., 2006) .
Some evidence indicates that early oxytocin administration is associated with an increase in spontaneous vaginal birth (Wei et al., 2009 ) but others conclude that oxytocin does not affect delivery mode (Bugg et al., 2013) . Likewise, there is no consensus regarding doses of oxytocin (Xenakis et al., 1995; Oscarsson et al., 2006; Hayes and Weinstein, 2008) . Systematic reviews of high versus low dose oxytocin for augmentation of delayed labour report shorter labour duration and an increase in spontaneous vaginal birth associated with high doses (Wei et al., 2010; Mori et al., 2011) but there are few studies and, overall, the evidence is scarce (Mori et al., 2011) . This would appear to indicate that further research should be conducted, and therefore the outcome measures chosen should receive some attention.
Healthy outcomes and positive experiences are core issues for women in childbirth, yet the majority of outcome measures used in research are focussed on physical aspects only and refer to adverse outcomes (for example, pain requiring analgesia, admission to Special Care Baby Unit (SCBU), mortality). There is a need for inclusion of positive health-focussed outcome measures using a salutogenic approach. Salutogenesis concentrates on health and how it can be promoted, rather than focussing on illness and how it can be cured (Day-Stirk and Palmer, 2003) , which is in congruence with the philosophy of childbirth that views pregnancy as a normal physiological event, not an illness. Smith et al. (2014) , in a systematic review of 102 systematic reviews of maternity care, identified 16 categories of outcomes that could be called 'salutogenic'; these included mobility during labour, comfort, spontaneous rupture of membranes, intact perineum, well-being, and positive relationship with infant. Focussing on such outcomes may encourage clinicians to try to increase their incidence, thus improving care for mothers and infants.
Some positive outcomes are expected from oxytocin (e.g. shorter labour duration, spontaneous vaginal birth), but it is acknowledged as not only a powerful and effective drug (Clark et al., 2009; Rooks, 2009) but also one that is associated with adverse neonatal outcome and operative delivery (Bugg et al., 2006; Oscarsson et al., 2006) . There is little evidence on the general impact of oxytocin during delay of labour, except that it shortens labour (Wei et al., 2009; Bugg et al., 2013; Mori et al., 2011) . A good maternal and fetal outcome is the overall aim for each labour and birth. However, comparisons between studies are challenging due to inconsistencies in choice, and definitions, of outcome variables, which indicates the need to develop a core set of outcomes (Devane et al., 2007) . It remains unclear how, or if, the outcomes identified by Devane et al. (2007) (including maternal mortality, caesarean section rates, length of labour, analgesia, mode of vaginal birth, post partum haemorrhage, blood transfusion, Apgar scores, admission to SCBU, perinatal mortality or morbidity), and other more positive health-focussed outcomes, have been picked up in the light of the ongoing research on oxytocin during delay in labour.
This systematic review aims to identify primary and secondary outcome measures in randomised trials, and systematic reviews of randomised trials, measuring effectiveness of oxytocin for treatment of delay in the first and second stages of labour. The review will also identify any positive health-focussed outcome measures used in this field.
Methods
Two of the authors performed a systematic search in March 2011, which was updated in January 2013, using the following databases:
Maternity and Infant Care (MIDIRS). Cochrane Database of Systematic Reviews (CDSR). Cochrane Central Register of Controlled Trials (CENTRAL). Medical Literature Analysis and Retrieval System Online (MEDLINE).
The Cumulative Index to Nursing and Allied Health Literature (CINAHL).
Exerpta Medica Database (EMBASE). Database of Abstracts of Reviews of Effects (DARES). Health Technology Assessment Database.
A detailed search strategy was developed and tested for each database, restricted to English language publications. Appropriate keywords were combined with the Boolean operands 'and' and 'or' as appropriate; for example, for a search in MEDLINE, 'delay OR delayed OR progressn OR augmentn OR dystocn OR slow OR arrested OR latent OR prolonged OR protracted OR active management OR partogram OR timing.' We also hand-searched the reference lists of all eligible studies for references to other possibly relevant studies. A flow diagram was produced (Fig. 1 ) to represent our search technique and results in accordance with the PRISMA statement (Liberati et al., 2009 ).
Eligibility criteria
We included randomised controlled trials (RCTs), and systematic reviews of RCTs. All studies used oxytocin for the treatment of delay in the first and second stage of labour as defined by the trial authors (e.g. delay of labour, slow progress for labour, prolonged labour, prolonged latent labour, late timing, diagnosis of arrested labour, no cervical change for two hours, no descent of the head). We excluded studies that compared the use of different partogram action lines, as the main focus was not on oxytocin. Studies that evaluated the use of active management of labour were also excluded, because these studies applied a package of care, which would have influenced the outcomes chosen.
Data collection and analysis
Our search identified 1918 citations after removal of duplicates, of which 1885 were excluded. Each identified citation was reviewed independently by all review authors, working in pairs, and filtered through three screening levels i.e., (i) title screening (ii) title and abstract screening and (iii) full-text screening. Disagreement at any level was resolved through discussion between two reviewers with recourse to a third reviewer if required.
There were a number of papers where it was difficult to reach a decision as to whether the study looked at Active Management of Labour (AML), which was to be excluded, or oxytocin used for treatment of delay, which should be included. For example, Cohen et al.'s paper (1987) was eventually excluded, after much discussion. The authors said 'all subjects demonstrated an inadequate pattern defined as a frequency of less than three contractions lasting 40 seconds each in a 10-minute time period' (p. 1175), which could have indicated delay, or perhaps just the latent phase of labour. As 'the early aggressive management protocol' was instituted 'within 30 minutes of admission to the labour ward' it seemed to be more like AML than waiting and eventually diagnosing delay in labour, therefore it was thought reasonable to judge this study as outside the scope of the review.
We finally included 28 papers, on 26 studies, for which data were extracted (Fig. 1) . All papers except Sharami et al. (2012) were available as full text papers, and all provided an abstract. More recent papers had structured abstracts but this was less the case if the papers were published earlier. Two papers reported on different aspects of the same study Steer, 1987a, 1987b) and one paper (Bergqvist et al., 2012) reported on a subsample of the study reported by Dencker et al. (2009) . All included original studies (n¼ 26) were randomised controlled trials where at least one of the groups received oxytocin for augmentation for delay in spontaneous labour (Table 1) .
Five systematic reviews of randomised trials were also included. In the five reviews there was a total of 45 included trials but several of these were already included in our review as individual studies, and many were included several times as they occurred in more than one review. The reviews included both randomised (and quasi randomised) trials, and both published and unpublished studies (Table 2 ). No quality assessment was made of selected papers and reviews, as only outcomes were to be counted, not results. Similarly, results are not included in the tables, as the focus is on outcomes measured.
Data were collected into a pre-prepared form by three authors and checked by three others. We counted all maternal and fetal outcomes used in the RCTs or specified a priori as outcomes in the reviews, and presented them as frequencies. Not all studies distinguished between primary and secondary outcomes. For the purposes of this review, outcomes were deemed to be 'primary' when the study authors presented them as such, or used a small number of outcomes in the power computation for sample size calculations. Other outcomes were then deemed to be 'secondary' (Table 3) . When a study presented a large number of outcomes without distinguishing between primary and secondary, they were all deemed to be secondary outcomes. Positive health focussedoutcomes, defined as outcomes tending toward the health, rather than pathological, end of the health continuum (e.g. spontaneous birth, intact perineum, breast feeding), and women-centred outcomes such as maternal satisfaction, were also noted.
Findings

Description of included original studies
Demographic characteristics
Most of the trials (25 out of 26) included nulliparous women with a single cephalic pregnancy (Table 1) . Eleven of these trials included both nulliparous and multiparous women. Only one study also included women with multiple pregnancies (Merrill and Zlatnik, 1999) . One study differed from the others and included only women with previous caesareans and 'unknown' scars (Grubb et al., 1996) . Women were most often randomised in the first stage of active labour but sometimes in early labour or in the second stage. Two studies (Saunders et al., 1989; Shennan et al., 1995) included only women using epidural analgesia. All trials included women at term and some studies also included women at an earlier gestational age (Table 1) .
Various exclusion criteria were defined. Several studies stated fetal related exclusion criteria as signs of 'fetal distress', estimated fetal macrosomia and known fetal anomalies. Other exclusion criteria included maternal fever/infection, abnormal bony pelvis, serious maternal disease, prolonged latent phase, high parity and contraindications for trial of labour.
The five reviews included both randomised and quasirandomised trials, and both published and unpublished studies. Four reviews included studies with both nulliparous and multiparous women. Fraser et al. (1998) included studies of nulliparous women only (Table 2) . Two reviews (Fraser et al., 1998; Wei et al., 2012) included both studies of management of delay in labour and studies of AML (Table 2 ). All included trials used oxytocin alone or in combination with artificial rupture of membranes as an intervention. There was a variation of study designs. Some studies compared high or low dose Steer, 1987a, 1987b; Merrill and Zlatnik, 1999; Majoko, 2001; Jamal and Kalantari, 2004 ) different increment intervals (Lazor et al., 1993) , different measures of (optimal) uterine contractions (Arulkumaran, 1989) , continuous versus pulsatile administration (Cummiskey et al., 1989; Tribe et al., 2012) , oxytocin versus other active drugs (Ho et al., 2010; Bleich et al., 2011) or in different combinations with placebo (Saunders et al., 1989; Shennan et al., 1995; Palomäki et al., 2006; Sharami et al., 2012) with or without artificial rupture of membranes (Rouse et al., 1994; Blanch et al., 2005; Nachum et al., 2010) or compared to expectancy (Bidgood and Steer, 1987a; Blanch et al., 2005; Hinshaw et al., 2008; Dencker et al., 2009) . Not all papers clearly defined the alternative treatment. Some of the studies did use an alternative treatment such as bath (Cluett et al., 2001 (Cluett et al., , 2004 , ambulation (Read et al., 1981; Hemminki et al., 1985) and breast or nipple stimulation (Curtis et al., 1999) . One study (Lazor et al., 1993) had an intervention also for women with induction of labour and here we only analysed the outcomes of the intervention for women receiving augmentation of labour. One study (Grubb et al., 1996) had an intervention with women in early labour (latent phase) and the intervention was that women with no contractions during four hours were sent home, whilst the other group stayed at hospital and were given oxytocin.
Outcome measures
A total of 23 outcome measures that were used in two or more studies or reviews were identified.
Primary outcome measures
The most frequently measured primary outcome was caesarean section, occurring in 15 of the 33 publications studied (46%). The length of labour was the next most frequently used (n ¼14, 42%), followed by measurements of uterine activity (e.g., hypertonus, uterine hyperstimulation) (n ¼13, 39%) and mode of vaginal birth (n ¼9, 27%). Umbilical artery pH and the progress of labour were assessed in six studies each (18%). Apgar score, admission to special care baby unit (SCBU), post partum haemorrhage (PPH), the timing and effect of oxytocin, neonatal/perinatal mortality or morbidity, birth weight and maternal mortality or serious morbidity were assessed as primary outcomes in only five (15%) ( Table 3) .
In relation to women-centred or positive health-focussed outcomes, maternal satisfaction was identified a priori by one review (Mori et al., 2011) , but was not included as a primary outcome in any individual study included in the review. Spontaneous birth was included only as part of the measurement of mode of birth. No further positive health-focussed outcomes could be identified.
Secondary outcome measures
Neonatal outcomes were more commonly assessed as secondary outcomes, with Apgar score/need for resuscitation used in 17 studies (52%) and admission to Special Care Baby Unit (SCBU) in 13 (39%). Post partum haemorrhage/blood transfusion, epidural/ analgesia used and the indication for caesarean section were measured in 11 studies (33%). Neonatal/perinatal mortality or morbidity, mode of vaginal birth, and the timing and effect of oxytocin were assessed as secondary outcomes in 10 studies (30%) ( Table 3) .
Maternal satisfaction was included as a secondary outcome by three papers (Blanch et al., 2005; Cluett et al., 2004; Nachum et al., 2010) and was identified a priori by one review (Wei et al., 2009) . One study measured women's perceptions of childbirth one month post partum (Bergqvist et al., 2012) . The review by Bugg et al. (2013) identified 'woman not satisfied' and 'care-giver not satisfied' as secondary outcomes, but these are negativelyphrased. One study measured rates of breast feeding on discharge (Hemminki et al., 1985) . No further women-centred, or positive health-focussed outcomes were identified.
Summative view on outcome measures
When all outcomes are combined, the findings demonstrate that more than half of all studies (n ¼ 22-17, 67-52%) assessed caesarean section rates, length of labour, Apgar score, uterine activity, admission to SCBU, and mode of vaginal birth (Table 3) . Nearly half measured post partum haemorrhage/blood transfusion, neonatal/perinatal mortality or morbidity, epidural/analgesia used and the timing and effect of oxytocin (n¼ 16-15, 49-46%) . At least one third (n ¼11-13, 33-39%) assessed umbilical artery pH, indication for caesarean section and serious maternal morbidity or death. Only five studies (15%) sought women's views on their experiences. A number of miscellaneous outcomes that were included in only one study each was also noted (Table 3) .
Discussion
Strengths and limitations
This review has analysed outcome measures used in randomised trials, which will enable clinicians to identify gaps in the published research and what outcomes should be included in future research. Complete retrieval of identified papers was achieved. No quality assessment was conducted as results of trials were not being analysed.
Main findings
This systematic review demonstrated that the majority of studies or reviews on using oxytocin to treat delayed progress in labour focus, understandably, on maternal and fetal birth outcomes including caesarean section rates, length of labour, Apgar scores, mode of vaginal birth, uterine activity, admission to SCBU, post partum haemorrhage/blood transfusion, perinatal mortality or morbidity, epidural/analgesia used and the timing and effect of oxytocin. These outcomes are well established and focus mostly on adverse facets. Even the systematic review that did include maternal satisfaction as an outcome, phrased it negatively (Mori et al., 2011) . Maternal satisfaction, although very important to include in all maternity care studies, is difficult to ascertain accurately as, even when mothers are not happy with the birth they experienced, they often report 'satisfaction' once a positive outcome has been achieved (Hodnett, 2002) . Despite these difficulties, an attempt at measuring maternal satisfaction should be made in all studies of interventions in childbirth.
Devane et al.'s Delphi study of 218 key stakeholders in maternity care (including maternity service users, paediatricians, obstetricians, midwives, general practitioners and policymakers), across 28 countries, outlined a core set of 48 key outcomes that they believed maternity care researchers should assess in future studies evaluating models of maternity care (Devane et al., 2007) . The majority of the top 10 outcomes given above were all found in the Delphi study; exceptions were outcomes particular to the type of study (uterine activity, tachysystole, timing and effect of oxytocin in various doses). However, seven arguably appropriate outcomes of the 48 derived from the Delphi study (birth injury to infant, anal sphincter damage, faecal incontinence, postnatal readmission of mother or neonate, postnatal depression, puerperal psychosis) (Devane et al., 2007) were used in none, or at the most, one, of the studies on using oxytocin to treat delay of progress in labour.
All studies in this review were randomised trials and the reviews were based on, or included, randomised trials. Results of other non-randomised studies regarding possible links between oxytocin use and these outcomes are conflicting, or non-existent. Clavicle damage (Lurie et al., 2011) and brachial plexus injury (Tandon and Tandon, 2005) are, for example, said to be associated with oxytocin use, but the confounding variables of fetal macrosomia and prolonged labour cloud this issue. Although some studies appear to show that oxytocin infusion can lead to anal sphincter damage (Jandér and Lyrenäs, 2001; Nakai et al., 2006) and/or faecal incontinence (Casey et al., 2005) , other large cohort studies disagree (Christianson et al., 2003; Jangö et al., 2012) . Postnatal readmission of mother or neonate is an outcome studied in relation to care pathways rather than individual intrapartum interventions, so this variable is not present in cohort studies on oxytocin use. No direct association has been shown between oxytocin use and postnatal depression, but postnatal depression is linked with postnatal readmission of the mother (Sword et al., 2011) . Given these tentative associations, or lack of evidence, these seven variables would thus be suitable outcomes to consider measuring in future randomised trials of oxytocin use.
Authors of the Delphi study noted that most items in the data set were phrased as adverse outcomes (Devane et al., 2007) . This is understandable, as the main purpose of most randomised trials is to test an intervention which sets out, first, to cause no injury and second, to improve birth outcomes for mother and infant. Similarly, almost none of the studies or systematic reviews included in this review refer to women-centred outcomes (e.g., maternal experience of pain, women's views of length of labour) or to positive health-focused outcomes (e.g., intact perineum, maternal self-esteem). Walsh has drawn attention to how women, when discussing their choice of place of birth, did not focus on doctors, provision of epidurals, or facilities for ventouse or caesarean births, so outcomes phrased in this way may have no great meaning for them. Instead, they spoke of the environment (how calm it was, or homely), the social aspect (near home, for visiting, or that family or friends had birthed there), and personal factors (friendliness of staff) (Walsh, 2007) . Understanding the importance of such factors may help clinicians to be more positive and mindful in their choice of language when talking with women, concentrating more on environmental, social and personal aspects than on adverse outcomes. Women-centred and positive-focussed outcomes are thus important to measure, in addition to those of interest to clinicians, so that we have results that are pertinent to women.
Phrasing outcomes in a more positive fashion can help to develop a salutogenic focus to health care, which may increase clients' 'sense of coherence' (Lindström and Eriksson, 2006) . This assists people, despite experiencing stressful situations, to develop resilience. The need for maternity care researchers to develop tools that measure 'optimality', or the best clinical outcome for the least intervention in childbirth, has been highlighted. An 'optimality index' has been developed and tested in a number of countries (Murphy and Fullerton, 2001; Sheridan and Sandall, 2010) and work is in progress on an international version.
Conclusion
It is recommended that, in future randomised trials of oxytocin use for slow progress in labour, a number of outcomes from the core data set developed by Devane et al. (2007) are measured to provide a more complete outcome picture for both mother and infant, in the short and long-term. In addition, including more women-centred and positive health-focussed outcomes may instil a more salutogenic culture in childbirth, with the potential to increase women's resilience and sense of coherence as they progress through childbirth.
